TY - JOUR
T1 - Evaluation of pharmacokinetics of bioreducible gene delivery vectors by real-time PCR
AU - Zhou, Qing Hui
AU - Wu, Chao
AU - Manickam, Devika Soundara
AU - Oupický, David
N1 - Funding Information:
This research was financially supported by the National Institutes of Health (CA 109711). We thank Drs. Amjad and Cha of the Anti-Infective Research Laboratory of Wayne State University for help with RT-PCR.
PY - 2009/7
Y1 - 2009/7
N2 - Purpose: To investigate pharmacokinetics of reversibly stabilized DNA nanoparticles (rSDN) using a single-step lysis RT-PCR. Methods: rSDN were prepared by coating bioreducible polycation/DNA polyplexes with multivalent N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers. Targeted polyplexes were formulated by linking cyclic RGD ligand (c(RGDyK)) to the HPMA surface layer of rSDN. The pharmacokinetic parameters in tumor-bearing mice were analyzed by PKAnalyst®. Results: The pharmacokinetics of naked plasmid DNA, simple DNA polyplexes, rSDN, and RGD-targeted rSDN exhibited two-compartment model characteristics with area under the blood concentration-time curve (AUC) increasing from 1,102 ng·ml-1·min-1 for DNA to 3,501 ng·ml-1·min-1 for rSDN. Non-compartment model analysis revealed increase in mean retention time (MRT) from 4.5 min for naked DNA to 22.9 min for rSDN. Conclusions: RT-PCR is a sensitive and convenient method suitable for analyzing pharmacokinetics and biodistribution of DNA polyplexes. Surface stabilization of DNA polyplexes can significantly extend their MRT and AUC compared to naked DNA. DNA degradation in rSDN in blood circulation, due to a combined effect of disulfide reduction and competitive reactions with charged molecules in the blood, contributes to DNA elimination.
AB - Purpose: To investigate pharmacokinetics of reversibly stabilized DNA nanoparticles (rSDN) using a single-step lysis RT-PCR. Methods: rSDN were prepared by coating bioreducible polycation/DNA polyplexes with multivalent N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers. Targeted polyplexes were formulated by linking cyclic RGD ligand (c(RGDyK)) to the HPMA surface layer of rSDN. The pharmacokinetic parameters in tumor-bearing mice were analyzed by PKAnalyst®. Results: The pharmacokinetics of naked plasmid DNA, simple DNA polyplexes, rSDN, and RGD-targeted rSDN exhibited two-compartment model characteristics with area under the blood concentration-time curve (AUC) increasing from 1,102 ng·ml-1·min-1 for DNA to 3,501 ng·ml-1·min-1 for rSDN. Non-compartment model analysis revealed increase in mean retention time (MRT) from 4.5 min for naked DNA to 22.9 min for rSDN. Conclusions: RT-PCR is a sensitive and convenient method suitable for analyzing pharmacokinetics and biodistribution of DNA polyplexes. Surface stabilization of DNA polyplexes can significantly extend their MRT and AUC compared to naked DNA. DNA degradation in rSDN in blood circulation, due to a combined effect of disulfide reduction and competitive reactions with charged molecules in the blood, contributes to DNA elimination.
KW - Gene delivery
KW - Pharmacokinetics
KW - Real-time PCR
KW - Tumor targeting
UR - http://www.scopus.com/inward/record.url?scp=67349282739&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67349282739&partnerID=8YFLogxK
U2 - 10.1007/s11095-009-9847-9
DO - 10.1007/s11095-009-9847-9
M3 - Article
C2 - 19240986
AN - SCOPUS:67349282739
SN - 0724-8741
VL - 26
SP - 1581
EP - 1589
JO - Pharmaceutical Research
JF - Pharmaceutical Research
IS - 7
ER -